Active Ingredient: HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
Proprietary Name: HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG;0.1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A085771
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
